DPM Blogs

Are Runners Better Off Than They Were 30 Years Ago?

Doug Richie Jr. DPM FACFAS
5/17/10 | 3048 reads | 1 comments
In the book Born to Run, Christopher McDougall makes the observation that running injuries have not reduced in frequency over the past 30 years despite the perceived technical advances in athletic footwear over this same period of time. He suggests that runners have been ripped off by the hype and false claims made by running shoe manufacturers. While this assertion is partly true (overall running injury rates have not changed much in 30 years), the assumption that footwear has not improved the life of the runner is false. Read More.

Assessing And Understanding The Impact Of The Shoe Upper

Jenny L Sanders DPM
5/13/10 | 3459 reads | 0 comments
Having a better understanding of the anatomy of a shoe can be helpful in advising patients on shoewear, particularly when there is foot deformity or irritation from shoes. With this in mind, let us take a closer look at the upper of a shoe. Read More.

Spreading The Word About The Value Of Podopediatrics

Russell Volpe DPM
5/12/10 | 3389 reads | 0 comments
As podiatrists, we tend to think of ourselves as generalists who treat all kinds of foot ailments. We also tend to think of ourselves as specialists who have dedicated and focused expertise in the diseases of the foot. Read More.

Why You Should Not Write Off The Opening Base Wedge Osteotomy

William Fishco DPM FACFAS
5/7/10 | 8105 reads | 2 comments
When it comes to bunion surgery, we all have our “favorite” technique. Not only do we have a comfort level with the technique, we feel we can use this technique or simple modifications thereof to fix most bunion deformities. In this blog, I want to remind you of an old procedure that has become revitalized recently. Read More.

Is Cheilectomy An Option For End-Stage Hallux Rigidus?

Neal Blitz DPM FACFAS
5/4/10 | 11498 reads | 1 comments
Foot surgeons are well aware of the various surgical procedures that address the various stages of degeneration of the big toe joint. As the severity of arthritis becomes more involved, so do the surgical interventions. Read More.

Are You Doing Your Part To Make Vision 2015 A Reality?

Kathleen Satterfield DPM FACFAOM
4/30/10 | 3975 reads | 0 comments
Did you meet the deadline for your Vision 2015 assignment? You had better check to make sure because you are on the line for getting this done. What? You thought this was an American Podiatric Medical Association (APMA) deal? Well, most of us did but at the APMA House of Delegates meeting, it became imminently clear that the APMA alone can not accomplish this paradigm shift. It will take everyone — from the executive director to the last student admitted to a podiatry college — to accomplish parity with our allopathic colleagues. Read More.

Can 'Chemovac' Dressings Be A Valuable Addition To Wound Care?

David G. Armstrong DPM MD PhD
4/27/10 | 3296 reads | 1 comments
Editor's note: This blog entry is co-authored by Nicholas Giovinco, BS. As one might imagine, the use of chemotherapeutic modalities is generally easy. Topical applications and traditional dressing modifications are, in many instances, technically unchanged from standard practice. Our experience with the application of “chemovac” dressings (combining chemotherapeutic dressings with negative pressure wound therapy (NPWT)). Read More.

Do Advances In Plantar Fasciitis Treatment Hold Up To Scientific Scrutiny?

Allen Jacobs DPM FACFAS
4/27/10 | 7610 reads | 7 comments
I am constantly amazed at the variety of treatment modalities that are effective for plantar fasciitis. In fact, I am amazed when a modality exists that is not effective for plantar fasciitis. Just think about all that you learn at conferences, see in exhibit halls and read in non-peer reviewed journals. You would have to be an idiot not to be able to cure plantar fasciitis. Read More.

Which Dermatological Vehicle Is Best For Your Patient?

Tracey Vlahovic DPM
4/22/10 | 4538 reads | 0 comments
Topical dermatological products allow direct treatment of a skin condition with fewer side effects than those associated with systemic agents. These products have a key component in addition to the active ingredient: the vehicle. The dermatological vehicle houses and supports the active ingredient. Read More.